Dr LEE Ming-Yueh 李明月医生

 Qualification / Profile    Surgical Experiences      Clinical Experiences    Professional Affliation    Publications  

About Dr Lee: Surgical Experiences


Dr LEE Ming-Yueh
  • Dr Lee had done thousands of cataract surgeries including conventional extra-capsular cataract extraction and phacoemulsification cataract surgeries.

  • She is a competent cataract surgeon who can handle complicated cataract cases like cataract in angle closures, pseudoexfoliative syndrome, hypermature cataract and subluxated cataract.

  • She has keen interest in premium intra-ocular lens and has implanted numerous Toric IOL and Multifocal IOL.

  • As a qualified Glaucoma Specialist, she performs standard trabeculectomy adheres to Moorfields Safe Surgery System. She also performs Glaucoma Tube-Shunt surgeries with Glaucoma Drainage Devices implants.

  • She also performs Minimal Invasive Glaucoma Surgery (MIGS) likes Xen Gel stent, i-Stent & i-Stent inject, Hydrus microstent and Perseflo microshunt. She was the pioneer in Malaysia in the adaptation of Perseflo microshunt in Glaucoma Surgeries since the launch in year 2022. She is also the 1st Glaucoma Surgeon to obtain Certificate of Completion of Training for Hydrus microstent in Malaysia in March 2023.

  • She had done a great number of Glaucoma laser procedures in pediatric and adult patients.

  • Dr Lee is an accomplished Glaucoma Surgeon who can handle both adult and children glaucoma cases.

  • Besides cataract and glaucoma surgeries, she had experiences in performing a wide range of ophthalmology surgeries/procedures including

    • pterygium excision with conjunctiva limbal graft
    • eyelids surgeries including incision and curettage of chalazion and eye abscess, Entropion correction for children and adults and Blepharoplasty
    • eye injuries including eyelids laceration, cornea-sclera toilet and suturing and repair of ruptured globe
    • eviseration and enucleation of eyeball
      management of diabetic retinopathy including laser procedures and intravitreal injection of anti-VEGF